Intravenous therapy IV therapy is the infusion of liquid substances directly into a vein. Intravenous simply means "within vein". Therapies administered intravenously are often called specialty pharmaceuticals.

Compared with other routes of administration, the intravenous route is the fastest way to deliver fluids and medications throughout the body. The bioavailability of the medication is 100% in IV therapy.

The majority of an IV solution is sterile water. Chemically, water is referred to as a “solvent.” A solvent is a substance that dissolves other materials called “solutes.” Within IV solutions, the solutes can be molecules called electrolytes (charged particles such as sodium, potassium, and chloride) and/or other larger compounds such as proteins or molecules.

Patient needs IV fluid therapy for maintenance (to supply daily needs), replacement (to replace deficit and on-going losses) and resuscitation (to correct an intravascular or extracellular deficit).Therefore, it is a good project for entrepreneurs to invest.

 

Few Indian Major Players are as under

·         Ahlcon Parenterals (India) Ltd.

·         Amanta Healthcare Ltd.

·         Goa Formulations Ltd.

·         Kokad Pharmaceutical Laboratories Ltd.

·         Parenteral Surgicals Ltd.

·         Punjab Formulations Ltd.

·         Senbo Industries Ltd.

·         Shree Krishna Keshav Laboratories Ltd.

·         Span Medicals Ltd.

·         Wockhardt Health Care Ltd.

 

Table of Contents

1.       City Profile & Geotechnical Site Characterization

1.1.    General

1.2.    Physical Characteristics

1.3.    Map

1.4.    Languages and Culture

1.5.    Climate &Rainfall

1.6.    Transportation and Communications

1.7.    Economy & Industry

2.       Introduction

3.       Types of IV Fluids

3.1.    Intravenous Fluids

3.2.    Colloid Solutions

3.3.    Crystalloid Solutions

3.4.    Hypertonic

3.5.    Hypotonic

3.6.    Lactated Ringer’s

3.7.    Normal saline solution

3.8.    5% Dextrose in water

3.9.    LR and NSS

3.10.Lactate Saline

3.11.Characteristics of Intravenous Fluids

4.       Uses And Applications

4.1.    Aims of Fluid Therapy

5.       Properties

6.       Market Survey

6.1.    Demand & Market Growth Rates of IV Fluid Sets In India

7.       Financials & Comparison of Major Indian Players/Companies

7.1.    About Financial Statements Of CMIE Database

7.2.    Profits & Appropriations

7.3.    Total Liabilities

7.4.    Total Assets

7.5.    Net Cash Flow From Operating Activities

7.6.    Section – I

7.6.1.Name Of Company With Contact Details

7.6.2.Name Of Director(S)

7.6.3.Plant Capacity

7.6.4.Location Of Plant

7.6.5.Name Of Raw Material(S) Consumed With Quantity & Cost

7.7.    Section – II

7.7.1.Assets

7.7.2.Cash Flow

7.7.3.Cost As % Ge Of Sales

7.7.4.Forex Transaction

7.7.5.Growth In Assets & Liabilities

7.7.6.Growth In Income & Expenditure

7.7.7.Income & Expenditure

7.7.8.Liabilities

7.7.9.Liquidity Ratios

7.7.10.    Profitability Ratio

7.7.11.    Profits

7.7.12.    Return Ratios

7.7.13.    Structure Of Assets & Liabilities (%)

7.7.14.    Working Capital & Turnover Ratios

8.       Export & Import Statistics Dataof India

8.1.    Export Statistics Data on IV Fluid

8.2.    Import Statistics Data on IV Fluid

8.3.    Export Statistics Data on Dialysis Solution

8.4.    Import Statistics Data on Dialysis Solution

9.       Present Manufacturers

10.   Product Description

10.1.Dextrose Monohydrate Solution

10.2.Dextrose 5%

10.3.Intravenous Fluid Packaging

10.4.Ringer's Lactate

10.5.Normal Saline Solution

10.6.Dialysis Solutions

10.7.Role of Solutions in Dialysis

10.8.Standard Water for Dialysis

11.   Raw Material Description

12.   Manufacturing Process

12.1.IV Bag Full Automatic Manufacturing Process:

13.   Plant and Machinery Details

14.   Process Flow Diagram

15.   Plant & Machinery Suppliers

15.1.Complete Machinery Suppliers

16.   Raw Material Suppliers

17.   Machinery, Raw Material & Product Photographs

17.1.Machinery Photographs

17.2.Raw Material Photographs

17.3.Product Photographs

18.   Plant Layout

 

PROJECT FINANCIALS

·         Project at a Glance

Annexure

·         Assumptions for Profitability workings ….…………………………………………....................... 1

·         Plant Economics…………………………………………………………………………….................... 2

·         Production Schedule……………………………………………………………………….................... 3

·         Land & Building…………………………………………………………………………….................... 4

§  Factory Land & Building

§  Site Development Expenses

·         Plant & Machinery………………………………………………………………………….................... 5

§  Indigenous Machineries

§  Other Machineries (Miscellaneous, Laboratory etc.)

·         Other Fixed Assets………………………………………………………………………….................... 6

§  Furniture & Fixtures

§  Pre-operative and Preliminary Expenses

§  Technical Knowhow

§  Provision of Contingencies

·         Working Capital Requirement Per Month………………………………………………................. 7

§  Raw Material

§  Packing Material

§  Lab & ETP Chemical Cost

§  Consumable Store

·         Overheads Required Per Month and Per Annum ……………………………………................. .8

§  Utilities & Overheads (Power, Water and Fuel Expenses etc.)

§  Royalty and Other Charges

§  Selling and Distribution Expenses

·         Salary and Wages ……………………………………………………………………………................. 9

·         Turnover Per Annum ………………………………………………………………………................ 10

·         Share Capital…………………………………………………………………………………................ 11

§  Equity Capital

§  Preference Share Capital

 

•        Annexure 1            ::        Cost of Project and Means of Finance

•        Annexure 2            ::        Profitability and Net Cash Accruals

§  Revenue/Income/Realisation

§  Expenses/Cost of Products/Services/Items

§  Gross Profit

§  Financial Charges    

§  Total Cost of Sales

§  Net Profit After Taxes

§  Net Cash Accruals

 

•        Annexure 3            ::        Assessment of Working Capital requirements

§  Current Assets

§  Gross Working Capital

§  Current Liabilities

§  Net Working Capital

§  Working Note for Calculation of Work-in-process

 

•        Annexure 4            ::        Sources and Disposition of Funds

•        Annexure 5            ::        Projected Balance Sheets

§  ROI (Average of Fixed Assets)

§  RONW (Average of Share Capital)

§  ROI (Average of Total Assets)

 

•        Annexure 6            ::        Profitability ratios

§  D.S.C.R

§  Earnings Per Share (EPS)

§  Debt Equity Ratio

 

•        Annexure 7            ::        Break-Even Analysis

§  Variable Cost & Expenses

§  Semi-Variable/Semi-Fixed Expenses

§  Profit Volume Ratio (PVR)

§  Fixed Expenses / Cost 

§  B.E.P

 

•        Annexure 8 to 11   ::        Sensitivity Analysis-Price/Volume

§  Resultant N.P.B.T

§  Resultant D.S.C.R

§  Resultant PV Ratio

§  Resultant DER

§  Resultant ROI

§  Resultant BEP

 

•        Annexure 12          ::        Shareholding Pattern and Stake Status

§  Equity Capital

§  Preference Share Capital

 

•        Annexure 13          ::        Quantitative Details-Output/Sales/Stocks

§  Determined Capacity P.A of Products/Services

§  Achievable Efficiency/Yield % of Products/Services/Items 

§  Net Usable Load/Capacity of Products/Services/Items   

§  Expected Sales/ Revenue/ Income of Products/ Services/ Items   

 

•        Annexure 14          ::        Product wise domestic Sales Realisation

•        Annexure 15          ::        Total Raw Material Cost

•        Annexure 16          ::        Raw Material Cost per unit

•        Annexure 17          ::        Total Lab & ETP Chemical Cost

•        Annexure 18          ::        Consumables, Store etc.

•        Annexure 19          ::        Packing Material Cost

•        Annexure 20          ::        Packing Material Cost Per Unit

•        Annexure 21          ::        Employees Expenses

•        Annexure 22          ::        Fuel Expenses

•        Annexure 23          ::        Power/Electricity Expenses

•        Annexure 24          ::        Royalty & Other Charges

•        Annexure 25          ::        Repairs & Maintenance Expenses

•        Annexure 26          ::        Other Manufacturing Expenses

•        Annexure 27          ::        Administration Expenses

•        Annexure 28          ::        Selling Expenses

•        Annexure 29          ::        Depreciation Charges – as per Books (Total)

•        Annexure 30          ::        Depreciation Charges – as per Books (P & M)

•        Annexure 31          ::        Depreciation Charges - as per IT Act WDV (Total)

•        Annexure 32          ::        Depreciation Charges - as per IT Act WDV (P & M)

•        Annexure 33          ::        Interest and Repayment - Term Loans

•        Annexure 34          ::        Tax on Profits

•        Annexure 35          ::        Projected Pay-Back Period And IRR